BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Biotech Beach

  EMD Serono and Takeda Join Rancho Biosciences as Charter Members of the Spatial Innovation Initiative

  Rancho Biosciences is pleased to announce its partnership with EMD Serono, Takeda and a top 10 pharma company as charter members of the groundbreaking Spatial Innovation Initiative.

  February 6, 2024

   · 

  2 min read
• Deals

  Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering

  Lineage Cell Therapeutics, Inc. today announced that it entered into a definitive agreement with certain investors for the purchase and sale of 13,461,540 of the company’s common shares in a registered direct offering at an offering price of $1.04 per common share.

  February 6, 2024

   · 

  6 min read
• Business

  AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development

  AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply.

  February 6, 2024

   · 

  4 min read
• Bio NC

  IQVIA Named to Fortune® World’s Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year

  IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, has been named to the Fortune® World’s Most Admired Companies™ list for the seventh consecutive year.

  February 6, 2024

   · 

  2 min read
• MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State

  MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company” or “MustGrow”) is pleased to announce receipt of The State of Oregon Agriculture Fertilizer Registration Certificate

  February 6, 2024

   · 

  7 min read
• Lone Star Bio

  FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

  FibroBiologics announced the issuance of three patents from the Japan Patent Office (JPO) to add to its portfolio.

  February 6, 2024

   · 

  3 min read
• New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine

  BioMed X and the Universitätsmedizin Mannheim announced today the publication of two manuscripts in the field of cancer immunology in the journal Science Advances.

  February 6, 2024

   · 

  5 min read
• Biotech Beach

  $9 million NIH grant advances drug to treat nicotine addiction

  Scientists at Camino Pharma, LLC, Sanford Burnham Prebys and University of California San Diego School of Medicine received a $9-million grant from the National Institute on Drug Abuse at the National Institutes of Health.

  February 6, 2024

   · 

  5 min read
• BioMidwest

  ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study

  ShiraTronics, Inc., a pioneering clinical-stage medical device company, today proudly announced the successful conclusion of enrollment in their pilot study conducted in Australia for their minimally invasive, implantable migraine therapy.

  February 6, 2024

   · 

  4 min read
• Drug Development

  Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences

  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the Journal of Biomedical Research and Environmental Sciences

  February 6, 2024

   · 

  7 min read